+------------------------------------------------------------------------------+
BUS 10/03 04:01 Salix Pharmaceuticals and Cosmo Technologies Announce Termination of Merger Agreement BN 10/03 04:07 *COSMO FOCUS ON FILING RIFAMYCIN SV, METHYLENE BLUE NDA BN 10/03 04:07 *COSMO FOCUS ON OBTAINING APPROVAL OF SIC-8000 BN 10/03 04:07 *COSMO SAYS TERMINATION NO EFFECT ON VALUE CREATION BN 10/03 04:06 *COSMO SAYS DEVELOPMENT PATH OF PIPELINE CONTINUES BN 10/03 04:06 *SALIX, COSMO MUTUALLY AGREED TO TERMINATE TRANSACTION BN 10/03 04:05 *SALIX SAYS CHANGED POLITICAL ENVIRONMENT CREATED UNCERTAINTY BN 10/03 04:04 *SALIX WILL MAKE $25M PAYMENT TO COSMO BFW 10/03 04:04 *SALIX, COSMO PHARMACEUTICALS TERMINATE MERGER PACT BN 10/03 04:03 *SALIX, COSMO PHARMACEUTICALS TERMINATE MERGER PACT BN 10/03 04:01 *SALIX PHARMACEUTICALS, COSMO TECHNOLOGIES TERMINATION OF PACT BN 10/03 04:01 *SALIX PHARMACEUTICALS, COSMO TECHNOLOGIES TERMINATE MERGER PACT BN 10/03 04:01 *SALIX PHARMACEUTICALS AND COSMO TECHNOLOGIES REPORT TERMINATION BN 10/03 04:01 *SALIX PHARMACEUTICALS, COSMO TECHNOLOGIES REPORT TERMINATION OF
+------------------------------------------------------------------------------+
Salix Pharmaceuticals, Cosmo Pharmaceuticals Cancel Merger Pact 2014-10-03 04:05:36.258 GMT
By Khalid Qayum Oct. 3 (Bloomberg) -- Cos. agree to terminate merger agreement under which Salix would have combined with Cosmo Technologies, according to statement. * Under terms Salix will make a $25m payment to Cosmo
Link to Statement:{NSN NCUOHOMEQTXC <GO>} Link to Company News:{COPN SW <Equity> CN <GO>} Link to Company News:{SLXP US <Equity> CN <GO>}
For Related News and Information: First Word scrolling panel: {FIRST<GO>} First Word newswire: {NH BFW<GO>}
To contact the reporter on this story: Khalid Qayum in Singapore at +65-6231-3413 or kqayum@bloomberg.net
To contact the editor responsible for this story: Jan Dahinten at +65-6212-1164 or jdahinten@bloomberg.net